Prostemics Co. Ltd (203690) — Cash Flow Reinvestment Rate

Latest as of December 2021: 5.52x

Prostemics Co. Ltd (203690) has a Cash Flow Reinvestment Rate of 5.52x as of December 2021, reinvesting ₩17.30 Billion (capex ₩17.30 Billion ) from operating cash flow of ₩3.13 Billion. Check 203690 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

5.52x
(Capex + Investments) / Operating CF

Total Reinvested

₩17.30 Billion
Capex + Investments

Operating Cash Flow

₩3.13 Billion
KRW

Capital Expenditures

₩17.30 Billion
KRW

Prostemics Co. Ltd Cash Flow Reinvestment Rate (2015–2021)

Historical reinvestment intensity for Prostemics Co. Ltd across 3 annual periods. Explore 203690 strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.

Annual Cash Flow Reinvestment Rate for Prostemics Co. Ltd (2015–2021)

Year-by-year capital reinvestment analysis for Prostemics Co. Ltd. For live market cap and broader valuation context, see 203690 market cap.

Year Reinvestment Rate Total Reinvested (KRW) Operating CF Capex YoY Change
2021 6.45x ₩19.39 Billion ₩3.00 Billion ₩17.30 Billion ▲ +267.0%
2016 1.76x ₩10.31 Billion ₩5.86 Billion ₩5.87 Billion ▲ +19.7%
2015 1.47x ₩9.17 Billion ₩6.25 Billion ₩7.12 Billion
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow